Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma
暂无分享,去创建一个
P. Hainaut | T. Decaens | P. Marche | G. Abbadessa | Yi Yu | N. Sturm | Z. Jílková | K. Kurma | B. Schwartz | Ayça Zeybek Kuyucu | Séyédéh Tayébéh Ahmad Pour | Gaël S. Roth